Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.
about
Impact of prescription size on statin adherence and cholesterol levelsAdoption of once-monthly oral bisphosphonates and the impact on adherence.Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trialAdherence to osteoporosis treatments: room for improvementAdherence and resource use among patients treated with biologic drugs: findings from BEETLE studyClinical practice guideline on diagnosis and treatment of hyponatraemia.Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.Changes of bone metabolism based on the different interventions with exercise type or additional intake material in ovariectomized rats.Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.Adherence and occurrence of fractures after switching to once-monthly oral bisphophonatesTreatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST studyMedication burden of Saudi Arabian women receiving antiresorptive therapyAlendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA resultsFighting the fracture cascade: evaluation and management of osteoporotic fractures.Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy.First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates.Osteoporosis update: effective prevention and treatment.The position of strontium ranelate in today's management of osteoporosis.Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.The role of risk communication in the care of osteoporosis.Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
P2860
Q33303944-E653BD39-9DBB-4C99-9DFD-716AD784BA73Q33701964-124D84B1-7B9C-47DE-9368-95301B3BD905Q33914033-75CA49B6-3FEE-4056-962D-30F0F913E302Q34033742-07D6D26E-D0E4-431A-BA0A-447F99B9C9CEQ34229494-BEAE208A-E40F-49A7-BAB2-5F85C532F1EAQ34406779-03858EBF-9EA8-41A7-9CA5-FFDF5E5422BFQ34441060-1A17BF47-A886-43C3-A848-027949520025Q34563514-D73EA9E1-02D0-4731-874D-D8C3F1965A8BQ34774658-77C2C605-675D-4B3A-A851-8F01BD205E80Q34821660-7CED88F4-7D31-4F57-9350-5FD0D34B5D5FQ35105035-07BB4EC0-DDE5-44C3-B811-E01DE8E0E9DCQ36311638-15BD7174-BDA2-48A4-84E1-EB13BCF1394AQ36922156-3D0DF1DD-F4D7-4549-B721-C0D8A44AEF91Q37008062-AD5975B1-F3FB-4605-94B0-DB0579287198Q37306068-DE4B4296-281A-45D9-8F9F-194943976FA1Q37329886-E82EAD3E-7B0E-45F8-B56E-DA6BFD0A842EQ37538469-2D6DC70E-AE91-4398-9E60-0AA19D0ABB53Q37638700-721EDFD9-8F7E-41CC-890A-23573F7133D1Q37763162-F7E5DC18-33FB-4B9E-8658-8557425C27F8Q38418620-E08F5FAB-97BB-46A3-889C-1270813ACA6FQ43606787-DB35B7F3-AF7B-4AF6-B332-EEBBF2055B06Q51577374-C6097ADB-0A8B-4A97-BDE1-81E6C53F176CQ51873934-30247D46-35A0-4680-AFDB-1ED6C83C5AA9Q58797068-A7BCDB46-2288-49DB-9237-C9661C475981
P2860
Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Persistence with bisphosphonat ...... nding the root of the problem.
@ast
Persistence with bisphosphonat ...... nding the root of the problem.
@en
type
label
Persistence with bisphosphonat ...... nding the root of the problem.
@ast
Persistence with bisphosphonat ...... nding the root of the problem.
@en
prefLabel
Persistence with bisphosphonat ...... nding the root of the problem.
@ast
Persistence with bisphosphonat ...... nding the root of the problem.
@en
P1476
Persistence with bisphosphonat ...... nding the root of the problem.
@en
P2093
Joyce A Cramer
Stuart Silverman
P356
10.1016/J.AMJMED.2005.12.018
P407
P433
P577
2006-04-01T00:00:00Z